October 3, 2025
1 min read

FDA launches generics pilot program, advances facility PreCheck proposal in bid to incentivize US drug manufacturing

The FDA unveiled a new pilot program that aims to speed up review times for generic drugmakers who test and manufacture their products in the U.S. Separately, the agency met with industry stakeholders this week to take comments on a proposed program to streamline the buildouts of new U.S. manufacturing plants.

Leave a Reply

Your email address will not be published.

Previous Story

Cidara snares up to $339M from BARDA to bankroll its non-vaccine flu candidate

Next Story

Eli Lilly earmarks $1B-plus for contract manufacturing partnerships in India

Previous Story

Cidara snares up to $339M from BARDA to bankroll its non-vaccine flu candidate

Next Story

Eli Lilly earmarks $1B-plus for contract manufacturing partnerships in India

Latest from Blog

NEWS CENTER Maine

Through in-depth storytelling, through direct contact on digital on social platforms, through long-standing community service programs like Coats & Toys for Kids, Project Heat and Buddy to Buddy, NEWS CENTER Maine is
Go toTop